As of a January 2026 legal analysis, BPC-157 remained listed in Category 2, and the compound cannot legally be compounded under sections 503A or 503B of the Food, Drug and Cosmetic Act
Riboflavin has therapeutic potential for certain mitochondrial disorders, such as mutations in the X-linked apoptosis-inducing factor mitochondria-associated 1 (AIFM1) and mitochondrial complex I deficiency nuclear type 20 or mitochondrial complex II deficiency ( Riboflavin also supports the antioxidant defense system by aiding the regeneration of other antioxidants, such as glutathione, from oxidized glutathione (GSSG), since riboflavin, in the form of FAD, is necessary for glutathione reductase to play its role in converting GSSG ( Vitamin B2 deficiency disrupts intermediary metabolism, potentially impairing energy production via the ETC, which is mainly concerned for the nervous system, given its high energy demands, and also can lead to disorders, such as migraine, because of energy failure, alongside overproduction of ROS (47)
Individuals seeking comprehensive glutathione and antioxidative support, those wanting detoxification support with the body's master antioxidant and its precursor, people seeking cellular health, immune response, and healthy aging support, and anyone wanting neuronal function and brain health support with P5P and glutathione.* Practitioner Reference S-Acetyl Glutathione Synergy is positioned within the Designs for Health Liver/Detoxification category
While BPC-157 focuses on localized tissue repair and new blood vessel formation, TB-500 works systemically to regulate cellular movement and reduce inflammation across the body
